Lauren Panco

START and OneOncology Partner To Expand Access to Early Phase Oncology Trials

Partnership Will Launch Three New START Research Sites to Bring Early Phase Trials Closer to Patients in Major U.S. Communities The START Center for Cancer Research (“START”), and OneOncology today announced a strategic partnership to launch early phase clinical trial sites. The rollout includes the Los Angeles Cancer Network (LACN, California), The Center for Cancer

START and OneOncology Partner To Expand Access to Early Phase Oncology Trials Read More »

START Doses First U.S. Patient in Moderna’s Phase 1 Clinical Trial of mRNA-4106, a Pan-Tumor Antigen Therapy Candidate, in Solid Tumors

Major study milestone highlights START’s commitment to bringing novel cancer therapies to patients through community-based early-phase clinical trials The START Center for Cancer Research (“START”), the world’s largest early-phase community-based oncology site network, today announced the dosing of the first U.S. participant in Moderna’s Phase 1 study evaluating mRNA-4106, a novel Pan-Tumor Antigen Therapy candidate, in

START Doses First U.S. Patient in Moderna’s Phase 1 Clinical Trial of mRNA-4106, a Pan-Tumor Antigen Therapy Candidate, in Solid Tumors Read More »

CURC

START Further Expands Its Global Oncology Site Network with the Addition of Carolina Urologic Research Center

START’s Site Network Solidifies its Global Leadership in Urological Cancer Trials The START Center for Cancer Research (“START”), a global leader in early-phase oncology clinical trials, announces the expansion of its network with the acquisition of Carolina Urologic Research Center (“CURC”) the premier urologic clinical research site specializing in genitourinary (GU) oncology. This acquisition strengthens

START Further Expands Its Global Oncology Site Network with the Addition of Carolina Urologic Research Center Read More »